{"entity":{"type":"insider","cik":"0001378683","url":"/insider/0001378683","json_url":"/insider/0001378683.json","name":"Winship M Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2009-03-06","last":"2015-10-23","span_basis":"filed_date"},"name_variants":[{"name":"Winship M Douglas","source":"filing","n_filings":3,"first_seen":"2009-03-06","last_seen":"2015-10-23"}],"transactions":[{"id":8450696,"accession":"0001161697-15-000446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000446","line_url":"/filing/0001161697-15-000446#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378683","owner_name":"Winship M Douglas","owner_display_name":"Winship M Douglas","owner_url":"/insider/0001378683","role":"Officer (VP, Regulatory Operations)","role_mark":"O","role_mark_label":"Officer (VP, Regulatory Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Regulatory Operations","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22800.0,"shares_display":"22,800","price_per_share":3.34,"price_display":"3.34","price_state":"stated","total_value":76152.0,"total_display":"76,152.00","total_whole":"76,152","shares_owned_after":74131.0,"shares_owned_after_display":"74,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-23","filed_date":"2015-10-23","scope":"insider"},{"id":3370620,"accession":"0001161697-12-000416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000416","line_url":"/filing/0001161697-12-000416#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378683","owner_name":"Winship M Douglas","owner_display_name":"Winship M Douglas","owner_url":"/insider/0001378683","role":"Officer (VP, Regulatory Operations)","role_mark":"O","role_mark_label":"Officer (VP, Regulatory Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Regulatory Operations","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":17294.0,"shares_owned_after_display":"17,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-24","filed_date":"2012-05-29","scope":"insider"},{"id":5749953,"accession":"0001161697-09-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-09-000245","line_url":"/filing/0001161697-09-000245#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378683","owner_name":"Winship M Douglas","owner_display_name":"Winship M Douglas","owner_url":"/insider/0001378683","role":"Officer (V.P. of Regulatory Operations)","role_mark":"O","role_mark_label":"Officer (V.P. of Regulatory Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P. of Regulatory Operations","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":4650.0,"total_display":"4,650.00","total_whole":"4,650","shares_owned_after":4794.0,"shares_owned_after_display":"4,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-06","filed_date":"2009-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Officer (VP, Regulatory Operations)","n_filings":3,"first_seen":"2009-03-06","last_seen":"2015-10-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378683","retrieved_at":"2026-08-22T07:01:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}